Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Long-Term Capital Lease Obligation : $0.64 Mil (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Zhong Yuan Bio-Technology Holdings Long-Term Capital Lease Obligation?

Zhong Yuan Bio-Technology Holdings's Long-Term Capital Lease Obligation for the quarter that ended in Sep. 2023 was $0.64 Mil.

Zhong Yuan Bio-Technology Holdings's quarterly Long-Term Capital Lease Obligation declined from Sep. 2022 ($0.61 Mil) to Mar. 2023 ($0.60 Mil) but then increased from Mar. 2023 ($0.60 Mil) to Sep. 2023 ($0.64 Mil).

Zhong Yuan Bio-Technology Holdings's annual Long-Term Capital Lease Obligation declined from Mar. 2021 ($0.94 Mil) to Mar. 2022 ($0.70 Mil) and declined from Mar. 2022 ($0.70 Mil) to Mar. 2023 ($0.60 Mil).

Zhong Yuan Bio-Technology Holdings Long-Term Capital Lease Obligation Historical Data

The historical data trend for Zhong Yuan Bio-Technology Holdings's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhong Yuan Bio-Technology Holdings Long-Term Capital Lease Obligation Chart

Zhong Yuan Bio-Technology Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Mar19

Mar20

Mar21

Mar22

Mar23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

0.17

0.94

0.70

0.60

Zhong Yuan Bio-Technology Holdings Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial								0.84	0.70	0.61	0.60	0.64

Zhong Yuan Bio-Technology Holdings (OTCPK:ZHYBF) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Zhong Yuan Bio-Technology Holdings Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Zhong Yuan Bio-Technology Holdings's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Zhong Yuan Bio-Technology Holdings Ltd (OTCPK:ZHYBF) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

28 Queen’s Road East, Suite 901, Tesbury Centre, Wanchai, Hong Kong, HKG

Website

https://www.zybioholdings.com

Zhong Yuan Bio-Technology Holdings Ltd is engaged in the business of developing and marketing nervonic acid-based health supplements and sales of acer truncatum seedlings. The company has two reportable segments such as sales of health care supplements and technical supporting services. The company generates its revenue primarily from the sales of health care supplements.

Executives

Tingting Chang	director, 10 percent owner, officer: CEO	RM 1002, 10THFL, LONG HU FUTURE OFFICE, NO. 1 EAST SHI LI PU ROAD, CHAO YANG DISTRICT, BEIJING F4 100024
James M Cassidy	director, 10 percent owner, officer: president,secretary,treasurer	215 APOLENA AVENUE, NEWPORT BEACH CA 92662
James K Mckillop	director, 10 percent owner, officer: Vice President	9454 WILSHIRE BOULEVARD, SUITE 612, BEVERLY HILLS CA 90212

Zhong Yuan Bio-Technology Holdings (Zhong Yuan Bio-Technology Holdings) Headlines

No Headlines